MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$14,865,177
Other income
(expense), net
$155,007
Change in fair value of
warrant liability
-$2,158
Net loss
-$8,913,649
Deemed dividends
$5,951,528
Total other income
(expense), net
$157,165
Loss from operations
-$9,070,814
Total operating
expenses
$9,070,814
General and
administrative
$5,006,957
Research and development
$4,063,857
Back
Back
Income Statement
source: myfinsight.com
REVELATION BIOSCIENCES, INC. (REVB)
REVELATION BIOSCIENCES, INC. (REVB)